1-3 of 3
Toshihisa Satta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd

Toshihisa Satta, Esperanza B. Papadopoulos, Boglarka Gyurkocza, Pamela Susman, Amandeep Singh, Marco Calafiore, Sergio A. Giralt, Miguel-Angel Perales, Jianmin Chen, Simon Li, Jonathan U. Peled, Marcel R.M. van den Brink, Alan M. Hanash, Doris M. Ponce
Journal: Blood
Blood (2023) 142 (Supplement 1): 7019.
https://doi.org/10.1182/blood-2023-181269
Published: 2023
Journal Articles

Outcomes and Management of Red Blood Cell Transfusions in Multiple Myeloma Patients Treated with Daratumumab

Ajai Chari, MD, Toshihisa Satta, Amit Tayal, Sundar Jagannath, MD, Hearn Jay Cho, MD PhD, Samir Parekh, MD, Kenneth Lau, Gillian Morgan, Donna Catamero, Juliet Escalon, Erika Florendo, Daniel Verina, Parul Doshi, Huaibao Feng, Clarissa Uhlar, Imran Khan, Tahamtan Ahmadi, Peter M. Voorhees, Maria-Victoria Mateos, Suzanne Arinsburg
Journal: Blood
Blood (2015) 126 (23): 3571.
https://doi.org/10.1182/blood.V126.23.3571.3571
Published: 2015
Journal Articles

Bayesian Network Meta-Analysis (NMA): Safety of Bortezomib, Thalidomide or Lenalidomide Containing Regimens for Transplant Ineligible Multiple Myeloma (MM) Patients

Toshihisa Satta, Norihiro Yamaguchi, Adriana Malone, MD, James Talcott, Ajai Chari, MD
Journal: Blood
Blood (2015) 126 (23): 3030.
https://doi.org/10.1182/blood.V126.23.3030.3030
Published: 2015